The United States assisted reproductive technology market size was valued at USD 6.4 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 11.0 Billion by 2034, exhibiting a CAGR of 5.95% during 2026-2034.

The market growth is primarily driven by increasing infertility rates, delayed pregnancies, and rising awareness of fertility preservation options such as egg freezing. Additionally, continuous advancements in in-vitro fertilization (IVF) techniques, embryo culture technologies, and genetic testing are significantly improving treatment outcomes and boosting adoption across fertility clinics in the country.

 

Get Insights on the United States Assisted Reproductive Technology Market Access the IMARC Sample Report: https://www.imarcgroup.com/united-states-assisted-reproductive-technology-market/requestsample

United States Assisted Reproductive Technology Market Trends:

Rising Demand for IVF and Fertility Preservation

The growing preference for IVF procedures, coupled with the increasing trend of egg and sperm freezing, is significantly shaping the ART landscape in the United States. Individuals are increasingly opting to delay parenthood due to career, financial stability, and lifestyle changes, thereby driving demand for advanced fertility solutions.

Integration of Genetic Testing and Precision Medicine

Preimplantation genetic testing (PGT) is becoming a critical component of ART procedures, enabling clinicians to identify genetic abnormalities and select the most viable embryos. This is improving success rates and reducing the risk of hereditary disorders, thereby strengthening overall market adoption.

Technological Advancements in IVF Laboratories

Artificial intelligence (AI), automation, and time-lapse embryo imaging systems are increasingly being used in fertility clinics to enhance embryo selection and improve success rates. These innovations are reducing manual errors, improving efficiency, and enabling more personalized fertility treatments.

United States Assisted Reproductive Technology Market Segmentation:

Analysis by Product:

  • Instrument
    • Sperm Separation System
    • Cryosystem
    • Incubator
    • Imaging System
    • Ovum Aspiration Pump
    • Cabinet
    • Micromanipulator
    • Laser Systems
    • Others
  • Accessory and Disposable
  • Reagents and Media
    • Cryopreservation Media
    • Semen Processing Media
    • Ovum Processing Media
    • Embryo Culture Media

The instrument segment leads the market due to increasing adoption of advanced IVF technologies such as incubators, micromanipulators, and imaging systems that improve embryo monitoring and treatment outcomes.

Analysis by Type:

  • In-Vitro Fertilization (IVF)
    • Fresh Donor
    • Frozen Donor
    • Fresh Non-Donor
    • Frozen Non-Donor
  • Artificial Insemination
    • Intrauterine Insemination
    • Intracervical Insemination
    • Intravaginal Insemination
    • Intratubal Insemination

IVF remains the dominant segment due to its higher success rates and increasing adoption among individuals facing complex infertility issues.

Analysis by End Use:

  • Fertility Clinics and Other Facilities
  • Hospitals and Others

Fertility clinics account for the largest share owing to specialized expertise, advanced technologies, and higher success rates in assisted reproductive procedures.

United States Assisted Reproductive Technology Market Regional Insights:

  • Northeast
  • Midwest
  • South
  • West

The Northeast region leads due to the presence of advanced fertility research centers and high adoption of cutting-edge reproductive technologies. The West region follows closely, driven by technological innovation and strong presence of leading fertility clinics.

Competitive Landscape:

The market is highly competitive with key players focusing on expanding fertility services, introducing advanced reproductive technologies, and investing in R&D. Strategic collaborations, clinic expansions, and adoption of AI-based reproductive tools are key strategies being used to strengthen market presence.

Latest Developments:

  • Fertility service providers are increasingly adopting AI-based embryo selection systems and automated IVF laboratory solutions to enhance treatment precision and success rates.
  • Expansion of fertility clinic networks across major U.S. regions is improving accessibility to assisted reproductive technologies.

United States Assisted Reproductive Technology Market Report Scope:

Report AttributeDetailsMarket Size in 2025USD 6.4 BillionMarket Forecast in 2034USD 11.0 BillionCAGR (2026–2034)5.95%Base Year2025Forecast Period2026–2034Historical Period2020–2025

Key Highlights:

  • Increasing infertility rates and delayed pregnancies are major growth drivers.
  • IVF and fertility preservation procedures are witnessing rising adoption.
  • AI, automation, and genetic testing are transforming treatment outcomes.
  • Fertility clinics dominate the end-use segment due to specialized services.
  • Northeast and West regions are key innovation hubs for ART services.

 

Author IMARC Group

 

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

 

Contact Us

 

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

United States: +1-201971-6302